Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy

Haidong Tang, Mingzhao Zhu, Jian Qiao, Yang Xin Fu

Research output: Contribution to journalReview articlepeer-review

46 Scopus citations


Tertiary lymphoid structures (TLS) often develop at sites of persistent inflammation, including cancers and autoimmune diseases. In most cases, the presence of TLS correlates with active immune responses. Because of their proximity to pathological loci, TLS are an intriguing target for the manipulation of immune responses. For several years, it has become clear that lymphotoxin (LT) signalling plays critical roles in lymphoid tissue organogenesis and maintenance. In the current review, we will discuss the role of LT signalling in the development of TLS. With a focus on cancers and autoimmune diseases, we will highlight the correlations between TLS and disease progression. We will also discuss the current efforts and potential directions for manipulating TLS for immunotherapies.

Original languageEnglish (US)
Pages (from-to)809-818
Number of pages10
JournalCellular and Molecular Immunology
Issue number10
StatePublished - Oct 1 2017


  • autoimmune disease
  • cancer
  • immunotherapy
  • lymphotoxin signalling
  • tertiary lymphoid structure

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases


Dive into the research topics of 'Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy'. Together they form a unique fingerprint.

Cite this